KCM
YARW

Kennedy Capital Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Kennedy Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,415
Closed -$942K – 616
2025
Q2 		$942K Buy
+11,415
New +$742K 0.02% 514

Other funds holding YARW

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Kennedy Capital Management's YARW Position: Q3 2025 in Review

Kennedy Capital Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2025, closing a stake of 11,415 shares — an estimated $942K sold.

Kennedy Capital Management first reported a position in YARW in Q2 2025 and held it in 1 quarter. The position peaked at $942K in Q2 2025. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

  • Kennedy Capital Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Kennedy Capital Management sold 11,415 Yarrow Bioscience, Inc. Common Stock shares in Q3 2025, an estimated $942K.
  • Kennedy Capital Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2025 and held it in 1 quarter.
  • Kennedy Capital Management's Yarrow Bioscience, Inc. Common Stock position peaked at $942K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2025.

Based on Kennedy Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.